Back to Search Start Over

Human leukocyte antigen (HLA) profile predicts severity of autoimmune liver disease in children of European ancestry

Authors :
Yüksel, Muhammed
Ma, Yun; Su, Haibin; Longhi, Maria Serena; McPhail, Mark J.; Wang, Pengyun; Bansal, Sanjay; Wong, Guan-Wee; Graham, Jonathon; Yang, Li; Thompson, Richard J.; Doherty, Derek G.; Hadzic, Nedim; Zen, Yoh; Quaglia, Alberto; Heneghan, Michael A.; Samyn, Marianne; Vergani, Diego; Mieli-Vergani, Giorgina
Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
Yüksel, Muhammed
Ma, Yun; Su, Haibin; Longhi, Maria Serena; McPhail, Mark J.; Wang, Pengyun; Bansal, Sanjay; Wong, Guan-Wee; Graham, Jonathon; Yang, Li; Thompson, Richard J.; Doherty, Derek G.; Hadzic, Nedim; Zen, Yoh; Quaglia, Alberto; Heneghan, Michael A.; Samyn, Marianne; Vergani, Diego; Mieli-Vergani, Giorgina
Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
Source :
Hepatology
Publication Year :
2021

Abstract

Background and aims: genetic predisposition to autoimmune hepatitis (AIH) in adults is associated with possession of human leukocyte antigen (HLA) class I (A*01, B*08) and class II (DRB1*03, -04, -07, or -13) alleles, depending on geographic region. Juvenile autoimmune liver disease (AILD) comprises AIH-1, AIH-2, and autoimmune sclerosing cholangitis (ASC), which are phenotypically different from their adult counterparts. We aimed to define the relationship between HLA profile and disease course, severity, and outcome in juvenile AILD. Approach and results: we studied 236 children of European ancestry (152 female [64%], median age 11.15 years, range 0.8-17), including 100 with AIH-1, 59 with AIH-2, and 77 with ASC. The follow-up period was from 1977 to June 2019 (median 14.5 years). Class I and II HLA genotyping was performed using PCR/sequence-specific primers. HLA B*08, -DRB1*03, and the A1-B8-DR3 haplotype impart predisposition to all three forms of AILD. Homozygosity for DRB1*03 represented the strongest risk factor (8.8). HLA DRB1*04, which independently confers susceptibility to AIH in adults, was infrequent in AIH-1 and ASC, suggesting protection; and DRB1*15 (DR15) was protective against all forms of AILD. Distinct HLA class II alleles predispose to the different subgroups of juvenile AILD: DRB1*03 to AIH-1, DRB1*13 to ASC, and DRB1*07 to AIH-2. Possession of homozygous DRB1*03 or of DRB1*13 is associated with fibrosis at disease onset, and possession of these two genes in addition to DRB1*07 is associated with a more severe disease in all three subgroups. Conclusions: unique HLA profiles are seen in each subgroup of juvenile AILD. HLA genotype might be useful in predicting responsiveness to immunosuppressive treatment and course.<br />Fifth Medical Center of PLA General Hospital; Roger Dobson Funds; King's College Hospital Charity; Medical Research Council Clinician Scientist Fellowship; Medical Research Council PhD Studentship; Alex Mowat PhD Studentship; King's College Hospital Charity; National Institute for Health Research University College London Hospital/University College London Biomedical Research Centre

Details

Database :
OAIster
Journal :
Hepatology
Notes :
pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1360583633
Document Type :
Electronic Resource